| Home | » Products | » Bulk Drugs | » 2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1 |
2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1
Product Code : BND2
Price And Quantity
- Minimum Order Quantity
- 10
- Unit of Measure
- Kilograms/Kilograms
Product Specifications
- Loss on Drying
- 0.5 %
- Molecular Weight
- 332.31 Kilograms (kg)
- Heavy Metal (%)
- 0.5 %
- Molecular Formula
- C16H16N2O6
- Storage
- Room Temperature
- Medicine Name
- 2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3-Carboxylic acid
- Chemical Name
- 2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3-Carboxylic acid
- CAS No
- 74936-72-4
- Type
- Pharmaceutical Intermediates
- Grade
- Medicine Grade
- Usage
- Niksan Pharmaceutical manufacturer, exporter and supplier of a wide range of 2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)- 1,4-Dihydropyridine-3-Carboxylic Acid. It’s mainly use in manufacturing of Barnidipine, Benidipine, Manidipine, Mepirodipine, Nicardipine, Lercanidipine, Pranidipine. Specifications :- Chemical Name : 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid CAS No : 74936-72-4 Molecular Formula : C16H16N2O6 Molecular Weight : 332.31 Purity : ≥98 % Assay : ≥98 % Application : Used in Barnidipine, Benidipine, Manidipine, Mepirodipine, Nicardipine, Lercanidipine, Pranidipine
- Purity(%)
- 98 %
- Appearance
- White or Yellow Powder
- Physical Form
- Solid
Product Description
CERTIFACATE OF ANALYSIS
| Product Name: 2,6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3-Carboxylic acid | |
| Batch No. : NSP/BND2/1701002 | Mfg. Date : January-2017 |
| CAS No. : 74936-72-4 | Retest Date : December-2019 |
| Tests | Requirements | Results |
| Description | White or Yellow Powder | Confirmed |
| Solubility | Soluble in 1N NaOH. Slightly soluble in DMF and Practically Insoluble in water | Confirmed |
| Water Content (By KF) | Not more than 0.5% w/w | 0.32%w/w |
| Identification | ||
| A) By UV | UV absorption of the sample must be concordant with the standard spectrum. | Confirmed |
| B) By IR | IR absorption of the sample must be concordant with the standard spectrum. | Confirmed |
| Residue after Ignition | Not more than 0.2% w/w | 0.07%w/w |
| Heavy metals | Not more than 20 ppm | Less than 20 ppm |
| Related substances (by HPLC) Individual known impurity Individual unknown impurity Total impurities |
Not more than 0.5% Not more than 0.5% Not more than 1.0% |
ND 0.18% 0.38% |
| Assay (By HPLC, on dried base) | Not less than 98.0% | 99.10%w/w |
| Conclusion | The material complies with respect to the above specification | |
Trade Information
- Payment Terms
- Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Cheque, Days after Acceptance (DA), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union, Paypal, Others
- Sample Policy
- Free samples are available
- Packaging Details
- HDPE drum with inner LPDE liners
- Main Export Market(s)
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- Main Domestic Market
- All India
- Certifications
- ISO, FDA, GMP
NIKSAN PHARMACEUTICAL
Ankleshwar, Gujarat, India
Ankleshwar, Gujarat, India
PLOT NO.. 4706/3, G.I.D.C ESTATE, SF-12, SHRINATHJI ARCADE, NEAR MEGHMANI CHOWKADI, Ankleshwar - 393002, Gujarat, India
Mr. Sanjay Patel
|
 |
NIKSAN PHARMACEUTICAL
All Rights Reserved.
|